Proteomic profiling of severe lung diffusion impairment in the recovery stage of COVID-19-induced ARDS

Autor: M C García-Hidalgo, J González, I D Benítez, S Santisteve, F Rodríguez-Jara, M Molinero, M Pérez-Pons, G Torres, A Moncusí-Moix, C Gort-Paniello, P Carmona, J Caballero, C Barberà, A P Tedim, R Almansa, A Ceccato, L Fernández-Barat, R Ferrer, D García-Casulla, R Menéndez, A Motos, Ó Peñuelas, J Riera, J F Bermejo-Martín, A Torres, F Barbé, D De Gonzalo-Calvo

Publikováno v: 03.03 - Mechanisms of lung injury and repair.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f2a0bfe235749de49bc13e2462199c60
https://doi.org/10.1183/13993003.congress-2022.632

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Proteomic profiling of lung diffusion impairment in the recovery stage of SARS-CoV-2-induced ARDS.

Autor: García-Hidalgo MC; Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain., González J; Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain., Benítez ID; Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain., Carmona P; Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain., Santisteve S; Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain., Moncusí-Moix A; Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain., Gort-Paniello C; Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain., Rodríguez-Jara F; Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain., Molinero M; Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain., Perez-Pons M; Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain., Torres G; Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain., Caballero J; Intensive Care Department, University Hospital Arnau de Vilanova, IRBLleida, Lleida, Spain., Barberà C; Intensive Care Department, University Hospital Santa María, IRBLleida, Lleida, Spain., Tedim AP; Hospital Universitario Río Hortega de Valladolid, Valladolid, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Almansa R; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.; Hospital Universitario Río Hortega de Valladolid, Valladolid, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Ceccato A; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain., Fernández-Barat L; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.; Servei de Pneumologia, Hospital Clinic, Universitat de Barcelona, IDIBAPS, Barcelona, Spain., Ferrer R; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.; Intensive Care Department, Vall d'Hebron Hospital Universitari, SODIR Research Group, Vall d'Hebron Institut de Recerca (VHIR), Spain., Garcia-Gasulla D; Barcelona Supercomputing Center (BSC), Barcelona, Spain., Menéndez R; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.; Pulmonology Service, University and Polytechnic Hospital La Fe, Valencia, Spain., Motos A; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.; Servei de Pneumologia, Hospital Clinic, Universitat de Barcelona, IDIBAPS, Barcelona, Spain., Peñuelas O; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.; Hospital Universitario de Getafe, Madrid, Spain., Riera J; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.; Intensive Care Department, Vall d'Hebron Hospital Universitari, SODIR Research Group, Vall d'Hebron Institut de Recerca (VHIR), Spain., Bermejo-Martin JF; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.; Hospital Universitario Río Hortega de Valladolid, Valladolid, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Torres A; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.; Servei de Pneumologia, Hospital Clinic, Universitat de Barcelona, IDIBAPS, Barcelona, Spain., Barbé F; Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain., de Gonzalo-Calvo D; Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.

Publikováno v: Clinical and translational medicine [Clin Transl Med] 2022 May; Vol. 12 (5), pp. e838.